Page last updated: 2024-09-05

5'-s-(2-aminoethyl)-n(6)-(4-nitrobenzyl)-5'-thioadenosine and Myelodysplastic Syndromes

5'-s-(2-aminoethyl)-n(6)-(4-nitrobenzyl)-5'-thioadenosine has been researched along with Myelodysplastic Syndromes in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gati, WP; Larratt, LM; Turner, AR1

Other Studies

1 other study(ies) available for 5'-s-(2-aminoethyl)-n(6)-(4-nitrobenzyl)-5'-thioadenosine and Myelodysplastic Syndromes

ArticleYear
Cellular abundance of es nucleoside transporters and differential drug toxicity in myelodysplastic syndrome (MDS) bone marrow cell subpopulations.
    Proceedings of the Western Pharmacology Society, 2001, Volume: 44

    Topics: Adenosine; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bone Marrow Cells; Carrier Proteins; Cell Survival; Cytarabine; Flow Cytometry; Fluorescent Dyes; Humans; Ligands; Membrane Proteins; Methotrexate; Myelodysplastic Syndromes; Nucleoside Transport Proteins; Thionucleosides

2001